University of Michigan researchers are rethinking how to approach antiphospholipid syndrome, an autoimmune disease often treated only after serious blood clots occur. Using artificial intelligence to analyze gene activity in patients’ blood, the team identified distinct immune patterns linked to the condition. The findings could help clinicians make more informed care decisions.
